ClinConnect ClinConnect Logo
Search / Trial NCT05378581

Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · May 16, 2022

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Virtual Reality Mask Children From 7 To 13 Allergic Pricks Tests Consultation And Pediatric's Day Hospital

ClinConnect Summary

This clinical trial is looking at how using a virtual reality mask can help children aged 7 to 13 feel less anxious and experience less pain during blood tests and skin prick tests for allergies. The researchers believe that the virtual reality experience might make these necessary medical procedures easier for kids by distracting them and reducing their fears.

To participate in this study, children must be between 7 and 13 years old and need to have blood tests or prick tests at specific hospitals in Clermont-Ferrand or Saint-Etienne. Parents must also agree to the child's participation and understand the study. However, some children may not be able to join if they have certain medical conditions, like heart disease or epilepsy, or if they have a history of motion sickness. If your child is eligible and chooses to take part, they will wear a virtual reality mask during the tests, which will hopefully improve their experience and make the procedures less stressful.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children from 7 to 13 years old requiring blood test and prick tests in pediatric consultation at the Clermont-Ferrand University Hospital and in the pediatric's day hospital at the Saint-Etienne University Hospital
  • Subjects and their parents who were informed about the study and gave informed consent
  • Enrollment in the Social Security system
  • Children and parents able to use the self-report scales proposed in the study
  • Exclusion Criteria:
  • Children from 7 to 13 :
  • presenting a contraindication to the use of the virtual reality mask: heart disease, epilepsy, psychiatric illness (major anxiety, post-traumatic stress disorder)
  • Having a modification of pain's integration (spina bifida for example)
  • Having received an analgesic before the care
  • Requiring contact isolation
  • With a history of seizures or motion sickness
  • Refusal of the parents and/or the child

About University Hospital, Clermont Ferrand

The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.

Locations

Clermont Ferrand, , France

Saint étienne, , France

Patients applied

0 patients applied

Trial Officials

Alexandra USCLADE

Principal Investigator

University Hospital, Clermont-Ferrand

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials